The American Journal of Managed Care

Streamlining Lymphoma Care With Multi-Indication Bispecifics

While multi-indication bispecific therapies are likely to expand in lymphoma, their use must remain driven by efficacy, with ...
Oncology Nurse Advisor

FDA Accelerated Approval for Oncology Drugs Leads to Improved Patient Survival

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.
Seeking Alpha

U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease

- Updated indication allows the use of RINVOQ ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom use of these treatments is clinically inadvisable ...
Forbes

Medicines Reimagined – Repurposing Drugs For New Indications

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...